EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Forte Biosciences, Inc. (FBRX) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-15.66M |
|
-- |
|
-- |
|
$16.12M |
|
$-16.12M |
|
$0.47M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-15.66M |
|
$-16.12M |
|
$-16.11M |
|
11.40M |
|
11.40M |
|
$-1.37 |
|
$-1.37 |
|
| Balance Sheet Financials | |
$47.16M |
|
$0.12M |
|
$0.30M |
|
$47.46M |
|
$9.03M |
|
-- |
|
-- |
|
$9.03M |
|
$38.43M |
|
$38.43M |
|
$38.43M |
|
6.58M |
|
| Cash Flow Statement Financials | |
$-10.36M |
|
$36.29M |
|
$-2.32M |
|
$22.24M |
|
$45.86M |
|
$23.61M |
|
$1.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-10.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-40.74% |
|
-40.74% |
|
-32.99% |
|
-40.74% |
|
$5.84 |
|
$-0.91 |
|
$-0.91 |
|